RU2017115341A3 - - Google Patents

Download PDF

Info

Publication number
RU2017115341A3
RU2017115341A3 RU2017115341A RU2017115341A RU2017115341A3 RU 2017115341 A3 RU2017115341 A3 RU 2017115341A3 RU 2017115341 A RU2017115341 A RU 2017115341A RU 2017115341 A RU2017115341 A RU 2017115341A RU 2017115341 A3 RU2017115341 A3 RU 2017115341A3
Authority
RU
Russia
Application number
RU2017115341A
Other languages
Russian (ru)
Other versions
RU2017115341A (en
RU2702362C2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52345359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2017115341(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2017115341A publication Critical patent/RU2017115341A/en
Publication of RU2017115341A3 publication Critical patent/RU2017115341A3/ru
Application granted granted Critical
Publication of RU2702362C2 publication Critical patent/RU2702362C2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
RU2017115341A 2014-11-05 2015-11-04 Pharmaceutical composition containing beta-blocker and angiotensin-converting enzyme inhibitor RU2702362C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1460654 2014-11-05
FR1460654A FR3027803B1 (en) 2014-11-05 2014-11-05 PHARMACEUTICAL COMPOSITION COMPRISING A BETABLOQUANT AND A CONVERSION ENZYME INHIBITOR
PCT/FR2015/052975 WO2016071631A1 (en) 2014-11-05 2015-11-04 Pharmaceutical composition comprising bisoprolol and perindoril

Publications (3)

Publication Number Publication Date
RU2017115341A RU2017115341A (en) 2018-11-05
RU2017115341A3 true RU2017115341A3 (en) 2019-05-21
RU2702362C2 RU2702362C2 (en) 2019-10-08

Family

ID=52345359

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017115341A RU2702362C2 (en) 2014-11-05 2015-11-04 Pharmaceutical composition containing beta-blocker and angiotensin-converting enzyme inhibitor

Country Status (24)

Country Link
EP (1) EP3215130B1 (en)
CY (1) CY1123322T1 (en)
DK (1) DK3215130T3 (en)
EA (1) EA032808B1 (en)
ES (1) ES2811904T3 (en)
FR (1) FR3027803B1 (en)
GE (1) GEP20196989B (en)
HR (1) HRP20201518T1 (en)
HU (1) HUE051947T2 (en)
LT (1) LT3215130T (en)
MA (1) MA40915B1 (en)
MX (1) MX2017005848A (en)
MY (1) MY187357A (en)
PH (1) PH12017500786B1 (en)
PL (1) PL3215130T3 (en)
PT (1) PT3215130T (en)
RS (1) RS60657B1 (en)
RU (1) RU2702362C2 (en)
SG (2) SG11201703550SA (en)
SI (1) SI3215130T1 (en)
TN (1) TN2017000170A1 (en)
UA (1) UA122131C2 (en)
WO (1) WO2016071631A1 (en)
ZA (1) ZA201703078B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2024004714A (en) 2021-10-20 2024-05-10 Servier Lab Novel trimetazidine salts.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092729A1 (en) 2002-05-03 2003-11-13 Hexal Ag Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
WO2007010501A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor
HU230877B1 (en) * 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stable pharmaceutical combination
AU2010242938A1 (en) * 2009-04-30 2011-11-17 Dr. Reddy's Laboratories Ltd. Fixed dose drug combination formulations
WO2011138772A1 (en) 2010-05-06 2011-11-10 Cal International Limited A pharmaceutical composition comprising aspirin and bisoprolol

Also Published As

Publication number Publication date
CY1123322T1 (en) 2021-12-31
HRP20201518T1 (en) 2020-12-11
UA122131C2 (en) 2020-09-25
ES2811904T3 (en) 2021-03-15
LT3215130T (en) 2020-08-25
PH12017500786A1 (en) 2017-10-02
RU2017115341A (en) 2018-11-05
WO2016071631A1 (en) 2016-05-12
FR3027803A1 (en) 2016-05-06
EA032808B1 (en) 2019-07-31
SG10201903656RA (en) 2019-05-30
SG11201703550SA (en) 2017-06-29
MA40915B1 (en) 2020-08-31
MY187357A (en) 2021-09-22
EP3215130A1 (en) 2017-09-13
PL3215130T3 (en) 2020-11-16
EP3215130B1 (en) 2020-07-08
SI3215130T1 (en) 2020-11-30
PH12017500786B1 (en) 2017-10-02
PT3215130T (en) 2020-08-26
MX2017005848A (en) 2017-06-27
FR3027803B1 (en) 2018-02-09
GEP20196989B (en) 2019-07-10
EA201790772A1 (en) 2017-09-29
HUE051947T2 (en) 2021-03-29
DK3215130T3 (en) 2020-09-21
TN2017000170A1 (en) 2018-10-19
ZA201703078B (en) 2020-11-25
RU2702362C2 (en) 2019-10-08
RS60657B1 (en) 2020-09-30

Similar Documents

Publication Publication Date Title
BR112016020776A2 (en)
BR112016021730A2 (en)
BR112016020566A2 (en)
BR112016016536A2 (en)
BR112016022474A2 (en)
BR112016021661A2 (en)
BR112016027071A2 (en)
BR112016021583A2 (en)
BR112016027638A2 (en)
BR112016026979A2 (en)
BR112016019462A2 (en)
BR112016016298A2 (en)
BR112016014434A2 (en)
BR112016015779A2 (en)
BR112016015645A2 (en)
BR112016027088A2 (en)
BR112016015963A2 (en)
BR112016021098A2 (en)
BR112016020595A2 (en)
BR112016016149A2 (en)
BR112016026642A2 (en)
BR112016019731A2 (en)
RU2016132785A3 (en)
BR112016019183A2 (en)
BR112016021347A2 (en)